Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.
About
BioLamina is a Stockholm-based biotech scale-up specializing in matrix biology and cell culture. Founded in 2009, the company develops and manufactures high-quality, chemically defined, and animal-origin-free human recombinant laminin-based cell culture substrates. These substrates are designed to enable the reliable growth and differentiation of pluripotent stem cells and other primary cells, which are crucial for advancing cell therapies for serious chronic diseases and enhancing the precision of cell-based models in drug discovery and development. BioLamina's products, such as Biolaminin® substrates, are used in cell therapy development, including clinical trials.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does BioLamina do?
BioLamina is a Stockholm-based biotech scale-up specializing in matrix biology and cell culture. Founded in 2009, the company develops and manufactures high-quality, chemically defined, and animal-origin-free human recombinant laminin-based cell culture substrates. These substrates are designed to enable the reliable growth and differentiation of pluripotent stem cells and other primary cells, which are crucial for advancing cell therapies for serious chronic diseases and enhancing the precision…
How much funding has BioLamina raised?
BioLamina has raised a total of $42M in funding. The most recent round on record is Venture Debt.
Where is BioLamina headquartered?
BioLamina is headquartered in Stockholm, Sweden.
When was BioLamina founded?
BioLamina was founded in 2009.
What industry does BioLamina operate in?
BioLamina operates in Biotechnology, Life Sciences, HealthTech, Cell Therapy, Biotech, MedTech.